Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3075025/0/en/Ardelyx-Presents-Data-Supporting-IBSRELA-tenapanor-at-Digestive-Disease-Week-2025-Conference.html
01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072782/0/en/Ardelyx-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070167/0/en/Ardelyx-Appoints-Merdad-Parsey-M-D-Ph-D-to-its-Board-of-Directors.html
24 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/24/3067378/0/en/Ardelyx-Announces-Three-Abstracts-Accepted-for-Poster-Presentations-at-Digestive-Disease-Week-2025-Conference.html
17 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/17/3063351/0/en/Ardelyx-to-Report-First-Quarter-2025-Financial-Results-on-May-1-2025.html
10 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/10/3059694/0/en/Post-Hoc-Analysis-of-the-OPTIMIZE-Study-Supporting-XPHOZAH-tenapanor-to-be-Presented-at-the-National-Kidney-Foundation-Spring-Clinical-Meetings.html
ABOUT THIS PAGE